You hit the nail on the head as to the reason for my frustration BDZ....at one point I got more than a bit exasperated and said that the June 30th "expectation" that I might as well toss it in the garbage because it seems to me the company has no real idea of when the trial is going to end dosing...so why not just be quiet about it. 

In fairness Paul said a few times that there are many people wanting guidance about end of dosing and event rates, not just me.....he didn't qualify who these other people are....they could be other shareholders, institutions, BP....I don't know because he didn't say and I didn't press. 

The impression he gave me is that they're struggling with the demand for information, but that there are many different moving parts etc etc...I just think its better to say nothing if things are that  uncertain.